Literature DB >> 11686962

Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.

E F Bell1, M J Acarregui.   

Abstract

BACKGROUND: Most premature infants are not sufficiently mature physiologically to take all of their required water and nutrients orally, and so they cannot regulate their own water intake. Thus, the caregiver must determine the amount of water to be given each day to such infants.
OBJECTIVES: The objective of this review is to examine the effects of water intake on postnatal weight loss and on the risks of dehydration, patent ductus arteriosus, necrotizing enterocolitis, bronchopulmonary dysplasia, intracranial hemorrhage, and death in premature infants. SEARCH STRATEGY: Randomized clinical trials were sought that compared the outcomes of interest in groups of premature infants who were given different levels of water intake according to experimental protocol. Such trials were sought in a previous review by one of the authors (Bell EF. Fluid therapy. In: Effective Care of the Newborn Infant, eds JC Sinclair, MB Bracken. Oxford: Oxford University Press, 1992: 59-72), in a list of trials provided by the Cochrane Neonatal Review Group, and in the authors' personal files. SELECTION CRITERIA: Only randomized clinical trials of varying water intake in premature infants are included. The review was limited to trials that included infants whose water intake was provided mainly or entirely by parenteral means. Studies were included regardless of outcomes examined. DATA COLLECTION AND ANALYSIS: Trials were selected by two reviewers, who also assessed the methodological quality of each trial. Data were independently extracted by the reviewers, and differences were reconciled. The data were then entered into tables using RevMan 3.1 for Windows. The adverse event rates were calculated for the restricted and liberal water intake groups for each dichotomous outcome, and the relative risk was computed. In addition, the maximal weight loss results were recorded, and the weighted mean difference was computed. The analyses (including calculation of relative risk, risk difference, and weighted mean difference) and tests of heterogeneity were accomplished with MetaView 3.1 software and a fixed effects model. No subgroup analyses were conducted. MAIN
RESULTS: The analysis of the four studies taken together indicates that restricted water intake significantly increases postnatal weight loss and significantly reduces the risks of patent ductus arteriosus, necrotizing enterocolitis, and death. With restricted water intake, there are trends toward increased risk of dehydration and reduced risk of bronchopulmonary dysplasia, but these trends are not statistically significant. REVIEWER'S
CONCLUSIONS: Based on this analysis, the most prudent prescription for water intake to premature infants would seem to be careful restriction of water intake so that physiological needs are met without allowing significant dehydration. This practice could be expected to decrease the risks of patent ductus arteriosus and necrotizing enterocolitis--and perhaps the overall risk of death--without significantly increased risk of adverse consequences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686962     DOI: 10.1002/14651858.CD000503

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  13 in total

Review 1.  Fluid restriction and prophylactic indomethacin in extremely low birth weight infants.

Authors:  Jasim A Anabrees; Khalid M Aifaleh
Journal:  J Clin Neonatol       Date:  2012-01

2.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

Review 3.  Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants.

Authors:  Edward F Bell; Michael J Acarregui
Journal:  Cochrane Database Syst Rev       Date:  2014-12-04

Review 4.  Necrotizing enterocolitis risk: state of the science.

Authors:  Sheila M Gephart; Jacqueline M McGrath; Judith A Effken; Melissa D Halpern
Journal:  Adv Neonatal Care       Date:  2012-04       Impact factor: 1.968

Review 5.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

Review 6.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

7.  Acute kidney injury in preterm infants admitted to a neonatal intensive care unit.

Authors:  Vesna Stojanović; Nenad Barišić; Borko Milanović; Aleksandra Doronjski
Journal:  Pediatr Nephrol       Date:  2014-05-17       Impact factor: 3.714

8.  Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.

Authors:  S Leroux; E Jacqz-Aigrain; V Elie; F Legrand; C Barin-Le Guellec; B Aurich; V Biran; B Dusang; S Goudjil; S Coopman; R Garcia Sanchez; W Zhao; P Manzoni
Journal:  Br J Clin Pharmacol       Date:  2018-06-21       Impact factor: 4.335

9.  Pharmacological closure of the patent ductus arteriosus.

Authors:  Sk Mehta; A Younoszai; J Pietz; Bp Achanti
Journal:  Images Paediatr Cardiol       Date:  2003-01

10.  Decreasing incidence of chronic lung disease despite the gradual reduction of postnatal dexamethasone use in very low birth weight infants.

Authors:  Chang Won Choi; Jong Hee Hwang; Jae Won Shim; Sun Young Ko; Eun Kyung Lee; Sung Shin Kim; Yun Sil Chang; Won Soon Park; Son Moon Shin
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.